Interaction Between Nitric Oxide Synthase and Cyclooxygenase Pathways in Osteoblastic MC3T3‐E1 Cells
暂无分享,去创建一个
Yoshiji Yamada | K. Ikeda | Yoshiji Yamada | Masahiro Kanematsu | Kyoji Ikeda | M. Kanematsu | Yoshiji Yamada
[1] N. Kurihara,et al. Inductive effects of prostaglandins on alkaline phosphatase in osteoblastic cells, clone MC3T3-E1. , 1985, Journal of biochemistry.
[2] S. Yamamoto,et al. Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor. , 1986, The Journal of biological chemistry.
[3] M. Currie,et al. Regulation of prostaglandin production by nitric oxide; an in vivo analysis , 1995, British journal of pharmacology.
[4] A. Ianaro,et al. Modulation by nitric oxide of prostaglandin biosynthesis in the rat , 1995, British journal of pharmacology.
[5] T. Evans,et al. Aminoguanidine selectively inhibits inducible nitric oxide synthase , 1993, British journal of pharmacology.
[6] L. Marnett,et al. Prostaglandin endoperoxide synthase: structure and catalysis. , 1991, Biochimica et biophysica acta.
[7] K. Ohya,et al. Expression of prostaglandin E receptor subtypes in bone: expression of EP2 in bone development. , 1995, Bone.
[8] A. Fujimori,et al. Cyclooxygenase inhibitors enhance cell growth in an osteoblastic cell line, MC3T3‐E1 , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] Shigehisa Yamamoto,et al. Establishment of a clonal osteogenic cell line from newborn mouse calvaria , 1981 .
[10] Roberto Pacifici,et al. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[12] H. Kawaguchi,et al. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. , 1993, The Journal of biological chemistry.
[13] M. Hirafuji,et al. Role of endogenous PGE2 in osteoblastic functions of a clonal osteoblast-like cell, MC3T3-E1. , 1994, Prostaglandins, leukotrienes, and essential fatty acids.
[14] C. Yallampalli,et al. Nitric oxide donor alleviates ovariectomy-induced bone loss. , 1996, Bone.
[15] Y. Vodovotz,et al. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta , 1993, The Journal of experimental medicine.
[16] P. Nibbering,et al. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. , 1994, The Journal of clinical investigation.
[17] S. Narumiya,et al. Prostaglandin E receptor subtypes in mouse osteoblastic cell line. , 1996, Endocrinology.
[18] M. Mcdaniel,et al. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. , 1993, Biochemistry.
[19] M. Currie,et al. Nitric oxide activates cyclooxygenase enzymes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Jilka,et al. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.
[21] J. Polak,et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. , 1995, Endocrinology.
[22] P. Hauschka,et al. Cytokines induce nitric oxide production in mouse osteoblasts. , 1994, Biochemical and biophysical research communications.
[23] H. Kawaguchi,et al. The role of prostaglandins in the regulation of bone metabolism. , 1995, Clinical orthopaedics and related research.
[24] P. López-Jaramillo,et al. The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.
[25] H. Datta,et al. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Cunningham,et al. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. , 1992, The Journal of biological chemistry.
[27] Y. Amagai,et al. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria , 1983, The Journal of cell biology.
[28] S. Ralston,et al. Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. , 1996, Bone.
[29] Y. Xia,et al. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. , 1993, Archives of biochemistry and biophysics.
[30] J. Vane,et al. A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2). , 1995, Advances in prostaglandin, thromboxane, and leukotriene research.
[31] S. Ralston,et al. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. , 1994, Endocrinology.
[32] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[33] Y. Xia,et al. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. , 1995, The Journal of clinical investigation.
[34] S. Srivastava,et al. Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] P. Collin‐Osdoby,et al. Bone cell function, regulation, and communication: A role for nitric oxide , 1995, Journal of cellular biochemistry.
[36] J. Riancho,et al. Expression and functional role of nitric oxide synthase in osteoblast‐like cells , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] D. Hwang,et al. Involvement of Reactive Oxygen Intermediates in Cyclooxygenase-2 Expression Induced by Interleukin-1 , Tumor Necrosis Factor-a , and Lipopolysaccharide , 2022 .
[38] R. Russell,et al. An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.
[39] S. Tannenbaum,et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.
[40] J. Morrow,et al. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Prystowsky,et al. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. , 1990, Gene.
[42] P. W. Johnston,et al. Nitric oxide: A cytokine‐induced regulator of bone resorption , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] S. Narumiya,et al. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. , 1994, Pharmacological reviews.
[44] P. Damoulis,et al. Nitric Oxide Acts in Conjunction with Proinflammatory Cytokines to Promote Cell Death in Osteoblasts , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[45] J. Roberts,et al. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. , 1995, Circulation research.
[46] S. Moncada,et al. The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.
[47] K. M. Davies,et al. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. , 1996, Methods in enzymology.
[48] T. Bringman,et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.
[49] T. Kasten,et al. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.